QIAGEN N.V. announced a non-U.S. offering of net share settled convertible bonds on August 28, 2025. The company plans to issue senior, unsecured convertible bonds due in 2032. The aggregate volume of the issuance is USD 750 million, with each bond issued in minimum denominations of USD 200,000. The bonds may be converted in part into ordinary shares of the company, with approximately 11.2 million shares underlying the bonds, representing about 5.1% of QIAGEN's current issued and outstanding share capital. The expected settlement date for the bonds is September 4, 2025. QIAGEN intends to use the net proceeds from the issuance for general corporate purposes, including refinancing existing indebtedness. The bonds will be traded on the Open Market (Freiverkehr) segment of the Frankfurt Stock Exchange. The final terms, including price and interest rate, are expected to be determined and announced later on August 28, 2025.